Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomized Controlled Clinical Trial of 3 Days Versus 5 Days Amoxicillin Dispersible Tablets for Chest-indrawing Childhood Pneumonia Among Children 2-59 Months of Age Presenting to Kamuzu Central Hospital in Lilongwe, Malawi

NCT02678195 is registered in ClinicalTrials.gov with Save the Children as lead sponsor.

NCT NCT02678195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02678195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomized Controlled Clinical Trial of 3 Days Versus 5 Days Amoxicillin Dispersible Tablets for Chest-indrawing Childhood Pneumonia Among Children 2-59 Months of Age Presenting to Kamuzu Central Hospital in Lilongwe, Malawi
Lead sponsor
Save the Children
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
December 31, 2019
Enrollment
3,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia